Up-regulation of CLDN1 in gastric cancer is correlated with reduced survival

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Eftang, Lars L ^a   Esbensen, Ying ^a   Tannæs, Tone M ^a   Blom, Gustav P ^a   Bukholm, Ida R K ^a   Bukholm, Geir ^b,c  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

Author keywords

cDNA microarray; Claudin 1; Gastric cancer; Helicobacter pylori; Interlukin 8; Prognosis; Survival

Indexed keywords

CLAUDIN 1; INTERLEUKIN 8;

AGED; ANGIOGENESIS; ARTICLE; CANCER SURVIVAL; CELL ADHESION; CLDN1 GENE; CLINICAL ARTICLE; CONTROLLED STUDY; DIGESTION; DOWN REGULATION; EXCRETION; FEMALE; GASTRITIS; GASTROINTESTINAL MUCOSA; GENE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HELICOBACTER INFECTION; HUMAN; HUMAN TISSUE; IL8 GENE; MALE; NONHUMAN; STOMACH ADENOCARCINOMA; STOMACH CANCER; UPREGULATION;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CLAUDIN-1; FEMALE; GASTRECTOMY; GASTRIC MUCOSA; GENE ONTOLOGY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TRANSCRIPTOME; UP-REGULATION;

EID: 84889854122     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-586     Document Type: Article

References (69)

1. Cancer registery of Norway Cancer in Norway 2010, Cancer incidence, mortality, survival and prevalence in Norway 2013, Oslo, Norway: Cancer Registry of Norway, Cancer registery of Norway.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Lyon 2010, France: International Agency for Research on Cancer, http://globocan.iarc.fr.
3. Takeno A, Takemasa I, Seno S, Yamasaki M, Motoori M, Miyata H, et al. Gene expression profile prospectively predicts peritoneal relapse after curative surgery of gastric cancer. Ann Surg Oncol 2010, 17:1033-1042. 10.1245/s10434-009-0854-1, 20012501.
4. Teramoto K, Tada M, Tamoto E, Abe M, Kawakami A, Komuro K, et al. Prediction of lymphatic invasion/lymph node metastasis, recurrence, and survival in patients with gastric cancer by cDNA array-based expression profiling. J Surg Res 2005, 124:225-236. 10.1016/j.jss.2004.10.003, 15820252.
5. Chen CN, Lin JJ, Chen JJ, Lee PH, Yang CY, Kuo ML, et al. Gene expression profile predicts patient survival of gastric cancer after surgical resection. J Clin Oncol 2005, 23:7286-7295. 10.1200/JCO.2004.00.2253, 16145069.
6. Motoori M, Takemasa I, Doki Y, Saito S, Miyata H, Takiguchi S, et al. Prediction of peritoneal metastasis in advanced gastric cancer by gene expression profiling of the primary site. Eur J Cancer 2006, 42:1897-1903. 10.1016/j.ejca.2006.04.007, 16831544.
7. Motoori M, Takemasa I, Yano M, Saito S, Miyata H, Takiguchi S, et al. Prediction of recurrence in advanced gastric cancer patients after curative resection by gene expression profiling. Int J Cancer 2005, 114:963-968. 10.1002/ijc.20808, 15645432.
8. Cho JY, Lim JY, Cheong JH, Park YY, Yoon SL, Kim SM, et al. Gene expression signature-based prognostic risk score in gastric cancer. Clin Cancer Res 2011, 17:1850-1857. 10.1158/1078-0432.CCR-10-2180, 3078023, 21447720.
9. Lauren P. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965, 64:31-49.
10. Correa P, Piazuelo MB. The gastric precancerous cascade. J Dig Dis 2012, 13:2-9. 10.1111/j.1751-2980.2011.00550.x, 3404600, 22188910.
11. Zabaleta J. Multifactorial etiology of gastric cancer. Methods Mol Biol 2012, 863:411-435. 10.1007/978-1-61779-612-8_26, 3625139, 22359309.
12. Hudler P. Genetic aspects of gastric cancer instability. Sci World J 2012, 2012:761909.
13. Nagini S. Carcinoma of the stomach: a review of epidemiology, pathogenesis, molecular genetics and chemoprevention. World J Gastrointest Oncol 2012, 4:156-169. 10.4251/wjgo.v4.i7.156, 3406280, 22844547.
14. Zheng HC, Li XH, Hara T, Masuda S, Yang XH, Guan YF, et al. Mixed-type gastric carcinomas exhibit more aggressive features and indicate the histogenesis of carcinomas. Virchows Arch 2008, 452:525-534. 10.1007/s00428-007-0572-7, 2329735, 18266006.
15. Yang X, Takano Y, Zheng HC. The pathobiological features of gastrointestinal cancers (Review). Oncol Lett 2012, 3:961-969. 3389636, 22783373.
16. Tan IB, Ng I, Tai WM, Tan P. Understanding the genetic basis of gastric cancer: Recent advances. Expert Rev Gastroenterol Hepatol 2012, 6:335-341. 10.1586/egh.12.7, 22646255.
17. Eftang LL, Esbensen Y, Tannaes TM, Bukholm IR, Bukholm G. Interleukin-8 is the single most up-regulated gene in whole genome profiling of H. pylori exposed gastric epithelial cells. BMC Microbiol 2012, 12:9. 10.1186/1471-2180-12-9, 3292955, 22248188.
18. Sipponen P, Price AB. The Sydney System for classification of gastritis 20 years ago. J Gastroenterol Hepatol 2011, 26(Suppl 1):31-34.
19. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996, 20:1161-1181.
20. Illumina I. HumanHT-12 v3 Expression BeadChip data sheet. http://www.illumina.com/Documents/products/datasheets/datasheet_humanht_12.pdf.
21. Illumina I. Illumina Annotation Files. http://support.illumina.com/downloads/humanht-12_v3_product_files.ilmn.
22. R: Development core team A language and environment for statistical computing 2008, Vienna, Austria: R Foundation for Statistical Computing, R: Development core team.
23. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004, 5:R80. 10.1186/gb-2004-5-10-r80, 545600, 15461798.
24. Dunning MJ, Barbosa-Morais NL, Lynch AG, Tavare S, Ritchie ME. Statistical issues in the analysis of Illumina data. BMC Bioinformatics 2008, 9:85. 10.1186/1471-2105-9-85, 2291044, 18254947.
25. Cairns JM, Dunning MJ, Ritchie ME, Russell R, Lynch AG. BASH: a tool for managing BeadArray spatial artefacts. Bioinformatics 2008, 24:2921-2922. 10.1093/bioinformatics/btn557, 2639304, 18953044.
26. Stavrum AK, Petersen K, Jonassen I, Dysvik B. Analysis of gene-expression data using J-Express. Curr Protoc Bioinformatics 2008, Chapter 7: Unit 7.3.
27. Breitling R, Armengaud P, Amtmann A, Herzyk P. Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett 2004, 573:83-92. 10.1016/j.febslet.2004.07.055, 15327980.
28. Draghici S, Khatri P, Bhavsar P, Shah A, Krawetz SA, Tainsky MA. Onto-tools, the toolkit of the modern biologist: Onto-express, onto-compare, onto-design and onto-translate. Nucleic Acids Res 2003, 31:3775-3781. 10.1093/nar/gkg624, 169030, 12824416.
29. Draghici S, Khatri P, Tarca AL, Amin K, Done A, Voichita C, et al. A systems biology approach for pathway level analysis. Genome Res 2007, 17:1537-1545. 10.1101/gr.6202607, 1987343, 17785539.
30. Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000, 28:27-30. 10.1093/nar/28.1.27, 102409, 10592173.
31. Khatri P, Sellamuthu S, Malhotra P, Amin K, Done A, Draghici S. Recent additions and improvements to the Onto-Tools. Nucleic Acids Res 2005, 33:W762-W765. 10.1093/nar/gki472, 1160233, 15980579.
32. ArrayExpress EMBL-EBI - functional genomics data. http://www.ebi.ac.uk/arrayexpress/.
33. Jung H, Jun KH, Jung JH, Chin HM, Park WB. The expression of claudin-1, claudin-2, claudin-3, and claudin-4 in gastric cancer tissue. J Surg Res 2011, 167:e185-e191. 10.1016/j.jss.2010.02.010, 20462599.
34. Iravani O, Tay BW, Chua PJ, Yip GW, Bay BH. Claudins and gastric carcinogenesis. Exp Biol Med (Maywood) 2013, 238:344-349. 10.1177/1535370213477981, 23759999.
35. Liu Y, Wang L, Lin XY, Wang J, Yu JH, Miao Y, et al. Anti-apoptotic effect of claudin-1 on TNF-alpha-induced apoptosis in human breast cancer MCF-7 cells. Tumour Biol 2012, 33:2307-2315. 10.1007/s13277-012-0493-1, 22941467.
36. Zavala-Zendejas VE, Torres-Martinez AC, Salas-Morales B, Fortoul TI, Montano LF, Rendon-Huerta EP. Claudin-6, 7, or 9 overexpression in the human gastric adenocarcinoma cell line AGS increases its invasiveness, migration, and proliferation rate. Cancer Invest 2011, 29:1-11. 10.3109/07357907.2010.512594, 20874001.
37. Chang TL, Ito K, Ko TK, Liu Q, Salto-Tellez M, Yeoh KG, et al. Claudin-1 has tumor suppressive activity and is a direct target of RUNX3 in gastric epithelial cells. Gastroenterology 2010, 138:255-265. 10.1053/j.gastro.2009.08.044, 19706291.
38. Resnick MB, Gavilanez M, Newton E, Konkin T, Bhattacharya B, Britt DE, et al. Claudin expression in gastric adenocarcinomas: a tissue microarray study with prognostic correlation. Hum Pathol 2005, 36:886-892. 10.1016/j.humpath.2005.05.019, 16112005.
39. Wu YL, Zhang S, Wang GR, Chen YP. Expression transformation of claudin-1 in the process of gastric adenocarcinoma invasion. World J Gastroenterol 2008, 14:4943-4948. 10.3748/wjg.14.4943, 2739949, 18756604.
40. Shibutani M, Noda E, Maeda K, Nagahara H, Ohtani H, Hirakawa K. Low expression of claudin-1 and presence of poorly-differentiated tumor clusters correlate with poor prognosis in colorectal cancer. Anticancer Res 2013, 33:3301-3306.
41. Nakagawa S, Miyoshi N, Ishii H, Mimori K, Tanaka F, Sekimoto M, et al. Expression of CLDN1 in colorectal cancer: a novel marker for prognosis. Int J Oncol 2011, 39:791-796.
42. Song X, Li X, Tang Y, Chen H, Wong B, Wang J, et al. Expression of claudin-2 in the multistage process of gastric carcinogenesis. Histol Histopathol 2008, 23:673-682.
43. Amasheh S, Meiri N, Gitter AH, Schoneberg T, Mankertz J, Schulzke JD, et al. Claudin-2 expression induces cation-selective channels in tight junctions of epithelial cells. J Cell Sci 2002, 115:4969-4976. 10.1242/jcs.00165, 12432083.
44. Furuse M, Furuse K, Sasaki H, Tsukita S. Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells. J Cell Biol 2001, 153:263-272. 10.1083/jcb.153.2.263, 2169456, 11309408.
45. Mima S, Takehara M, Takada H, Nishimura T, Hoshino T, Mizushima T. NSAIDs suppress the expression of claudin-2 to promote invasion activity of cancer cells. Carcinogenesis 2008, 29:1994-2000. 10.1093/carcin/bgn134, 18586689.
46. Rendon-Huerta E, Teresa F, Teresa GM, Xochitl GS, Georgina AF, Veronica ZZ, et al. Distribution and expression pattern of claudins 6, 7, and 9 in diffuse- and intestinal-type gastric adenocarcinomas. J Gastrointest Cancer 2010, 41:52-59. 10.1007/s12029-009-9110-y, 19960275.
47. Park JY, Park KH, Oh TY, Hong SP, Jeon TJ, Kim CH, et al. Up-regulated claudin 7 expression in intestinal-type gastric carcinoma. Oncol Rep 2007, 18:377-382.
48. Johnson AH, Frierson HF, Zaika A, Powell SM, Roche J, Crowe S, et al. Expression of tight-junction protein claudin-7 is an early event in gastric tumorigenesis. Am J Pathol 2005, 167:577-584. 10.1016/S0002-9440(10)62999-9, 1603560, 16049341.
49. Xuan J, Deguchi R, Yanagi H, Ozawa H, Urano T, Ogawa Y, et al. Relationship between gastric mucosal IL-8 levels and histological gastritis in patients with Helicobacter pylori infection. Tokai J Exp Clin Med 2005, 30:83-88.
50. Chiba T, Marusawa H, Seno H, Watanabe N. Mechanism for gastric cancer development by Helicobacter pylori infection. J Gastroenterol Hepatol 2008, 23:1175-1181. 10.1111/j.1440-1746.2008.05472.x, 18637055.
51. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992, 258:1798-1801. 10.1126/science.1281554, 1281554.
52. Hu DE, Hori Y, Fan TP. Interleukin-8 stimulates angiogenesis in rats. Inflammation 1993, 17:135-143. 10.1007/BF00916100, 7684027.
53. Heidemann J, Ogawa H, Dwinell MB, Rafiee P, Maaser C, Gockel HR, et al. Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2. J Biol Chem 2003, 278:8508-8515. 10.1074/jbc.M208231200, 12496258.
54. Kitadai Y, Takahashi Y, Haruma K, Naka K, Sumii K, Yokozaki H, et al. Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice. Br J Cancer 1999, 81:647-653. 10.1038/sj.bjc.6690742, 2362886, 10574250.
55. Kuai WX, Wang Q, Yang XZ, Zhao Y, Yu R, Tang XJ. Interleukin-8 associates with adhesion, migration, invasion and chemosensitivity of human gastric cancer cells. World J Gastroenterol 2012, 18:979-985. 10.3748/wjg.v18.i9.979, 3297059, 22408359.
56. Ju D, Sun D, Xiu L, Meng X, Zhang C, Wei P. Interleukin-8 is associated with adhesion, migration and invasion in human gastric cancer SCG-7901 cells. Med Oncol 2012, 29:91-99. 10.1007/s12032-010-9780-0, 21191670.
57. Schraufstatter IU, Chung J, Burger M. IL-8 activates endothelial cell CXCR1 and CXCR2 through Rho and Rac signaling pathways. Am J Physiol Lung Cell Mol Physiol 2001, 280:L1094-L1103.
58. Bartchewsky W, Martini MR, Masiero M, Squassoni AC, Alvarez MC, Ladeira MS, et al. Effect of Helicobacter pylori infection on IL-8, IL-1beta and COX-2 expression in patients with chronic gastritis and gastric cancer. Scand J Gastroenterol 2009, 44:153-161. 10.1080/00365520802530853, 18985541.
59. Noshiro M, Kusugami K, Sakai T, Imada A, Ando T, Ina K, et al. Gastric metaplasia in the duodenal bulb shows increased mucosal interleukin-8 activity in Helicobacter pylori-positive duodenal ulcer patients. Scand J Gastroenterol 2000, 35:482-489. 10.1080/003655200750023732, 10868450.
60. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum 1994, 61:1-241. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon.
61. Kato S, Matsukura N, Tsukada K, Matsuda N, Mizoshita T, Tsukamoto T, et al. Helicobacter pylori infection-negative gastric cancer in Japanese hospital patients: incidence and pathological characteristics. Cancer Sci 2007, 98:790-794. 10.1111/j.1349-7006.2007.00478.x, 17470129.
62. Kang HY, Kim N, Park YS, Hwang JH, Kim JW, Jeong SH, et al. Progression of atrophic gastritis and intestinal metaplasia drives Helicobacter pylori out of the gastric mucosa. Dig Dis Sci 2006, 51:2310-2315. 10.1007/s10620-006-9276-0, 17080249.
63. Economescu MC, Necula LG, Dragu D, Badea L, Dima SO, Tudor S, et al. Identification of potential biomarkers for early and advanced gastric adenocarcinoma detection. Hepatogastroenterology 2010, 57:1453-1464.
64. Su CQ, Qiu H, Zhang Y. Localization of keratin mRNA and collagen I mRNA in gastric cancer by in situ hybridization and hybridization electron microscopy. World J Gastroenterol 1999, 5:527-530.
65. Pluciennik E, Krol M, Nowakowska M, Kusinska R, Potemski P, Kordek R, et al. Breast cancer relapse prediction based on multi-gene RT-PCR algorithm. Med Sci Monit 2010, 16:CR132-CR136.
66. Miyata Y, Iwata T, Maruta S, Kanda S, Nishikido M, Koga S, et al. Expression of matrix metalloproteinase-10 in renal cell carcinoma and its prognostic role. Eur Urol 2007, 52:791-797. 10.1016/j.eururo.2006.12.028, 17207914.
67. Zhao ZS, Chu YQ, Ye ZY, Wang YY, Tao HQ. Overexpression of matrix metalloproteinase 11 in human gastric carcinoma and its clinicopathologic significance. Hum Pathol 2010, 41:686-696. 10.1016/j.humpath.2009.10.010, 20060156.
68. Yang YH, Deng H, Li WM, Zhang QY, Hu XT, Xiao B, et al. Identification of matrix metalloproteinase 11 as a predictive tumor marker in serum based on gene expression profiling. Clin Cancer Res 2008, 14:74-81. 10.1158/1078-0432.CCR-07-1179, 18172255.
69. Yamashita K, Azumano I, Mai M, Okada Y. Expression and tissue localization of matrix metalloproteinase 7 (matrilysin) in human gastric carcinomas. Implications for vessel invasion and metastasis. Int J Cancer 1998, 79:187-194. 10.1002/(SICI)1097-0215(19980417)79:2<187::AID-IJC15>3.0.CO;2-7, 9583735.